Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Vie Ventures is a venture capital firm founded by Steven St. Peter, MD, and Luke Evnin, PhD, located in Cambridge, Massachusetts. The firm specializes in developing therapeutics for autoimmune diseases and disorders of the immune system. They engage with disease-focused philanthropies to align financial returns with mission-driven impact.
Vie Ventures invests in therapeutic companies that are creating next-generation therapies for autoimmune diseases. Their approach emphasizes generating financial returns while making a mission-driven impact through strategic partnerships within the biotech sector.
Steven St. Peter, MD - Co-founder, brings extensive medical expertise in therapeutics. Luke Evnin, PhD - Co-founder, has a strong background in biotech innovation. Jeff Bluestone - Managing Director, known for his pioneering work in Treg research.
Email your pitch deck to contact@vieventures.com.
As of October 2023: Vie Ventures has been active in expanding its portfolio and thought leadership in the biotech space, publishing insights on biopharma predictions and purpose-aligned capital.
Vie Ventures focuses on therapeutic companies developing next-generation therapies for autoimmune diseases, aiming for both financial returns and mission-driven impact.
Vie Ventures was founded by Steven St. Peter, MD, and Luke Evnin, PhD, both of whom have significant experience in the biotech field.
Recently, Jeff Bluestone, a pioneer in Treg research, was appointed as Managing Director to enhance their portfolio in autoimmune therapeutics.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.